The ultimate goal is to establish a standardized and universally applicable procedure for assessing Ki-67 in HNSCC, thereby enhancing the accuracy and reliability of prognostic predictions in clinical settings. Here, MKI67 is linked to head and neck squamous cell carcinoma.